Attention-
Internal Medicine
2023-12-01

Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases

IMPORTANCE Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased substantially over the past decades. However, the potential risk of cardiovascular disease (CVD) associated with long-term ADHD medication use remains unclear. OBJECTIVE To assess the association between long-term use of ADHD medication and the risk of CVD. DESIGN, SETTING, AND PARTICIPANTS This case-control study included individuals in Sweden aged 6 to 64 years who received an incident diagnosis of ADHD or ADHD medication dispensation between January 1, 2007, and December 31, 2020. Data...

Internal Medicine
2023-11-29

Antiphospholipid Antibodies Increase Risk of Cardiovascular Disease in Patients With Lupus

Patients with systemic lupus erythematosus (SLE) who are positive for antiphospholipid (aPL) antibody isotypes immunoglobulin (Ig)G/IgM and lupus anticoagulant (LA) have an increased risk of atherosclerotic cardiovascular disease (ASCVD), according t...

Internal Medicine
2023-11-27

The cardiovascular effects of novel weight loss therapies

The prevalence of overweight and obesity has reached pandemic proportions. Obesity is known to increase the risk for Type 2 diabetes and hypertension, as well as the risk for overt cardiovascular (CV) disease, including myocardial infarction, heart f...

Videos from category: Cardiology

State of a
10:39

State of art lipid-lowering treatment in 2023

ESC 2023
The import
14:17

The importance of intensive lipid lowering in CV risk reduction: the role of early combination treatment

ESC 2023
Key points
7:23

Key points from the 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

ESC 2023
Heart Fail
2:32

Heart Failure management in the post-COVID era - Lessons from the pandemic

ESC 2023

Videos from category: Diabetology

Targeting
9:22

Targeting CV risk factors with GLP-1 RAs in people with obesity

EASD 2022
Once weekl
7:36

Once weekly insulin: The ONWARDS 2 study

EASD 2022
Is HFpEF h
20:42

Is HFpEF hiding in your practice? Key messages of the DELIVER study: Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

EASD 2022
Semaglutid
7:29

Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg

EASD 2022

Videos from category: Hematology

LMWH use i
6:49

LMWH use in pregnancy: The Highlow and the ALPINE trial

ASH 2022
Novelties
12:44

Novelties in the treatment of multiple myeloma 2021

ASH 2021
Risks for
5:01

Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology

ASH 2021
Novelties
8:35

Novelties in the treatment of myelofibrosis and polycythemia vera 2021

ASH 2021

Videos from category: Internal Medicine

Anticoagul
8:47

Anticoagulant Advancements for VTE in Children

ISTH 2022
The Journe
3:15

The Journey to Address Unmet Needs Across all Haemophilia Indications

ISTH 2022
Clinical C
6:18

Clinical Challenges in Patients with Venous Thromboembolism

ISTH 2022
Good pract
19:37

Good practice statements for antithrombotic therapy in the management of COVID-19

ISTH 2022

Videos from category: Oncology

Lung Cance
13:28

Lung Cancer highlights of ESMO 2023 Congress

ESMO 2023
Lung cance
10:26

Lung cancer highlights of the ESMO 2023 Congress

ESMO 2023
Melanoma h
8:15

Melanoma highlights of ESMO 2023 Congress

ESMO 2023
RCC highli
6:30

RCC highlights of ESMO 2023 Congress

ESMO 2023

Videos from category: Psychiatry

Current is
13:39

Current issues in the treatment of schizophrenia

EPA 2023
Highlights
10:47

Highlights of EPA 2023

EPA 2023
Novel Phar
8:13

Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

EPA 2021
Meeting th
15:41

Meeting the challenges of schizophrenia care during the COVID-19 pandemic

EPA 2021

Videos from category: Respiratory

Considerat
8:14

Considerations of moderate asthma management

ERS 2023
Choices in
10:06

Choices in asthma and COPD care: How to maximize outcomes for patients

ERS 2022
The digita
11:38

The digital age: The future of respiratory medicine

ERS 2021
Pulmonary
7:05

Pulmonary hypertension and interstitial pulmonary fibrosis

ERS 2021

Sixty Seconds Science

1:00
How to manage isolated systolic hypertension in the young?
1:34
Blood pressure monitoring in general and what we can do to encourage people.
1:08
How to manage masked and masked uncontrolled hypertension?
1:13
ESMO 2023 Scientific Chair's welcome and invitation to next year's ESMO Congress
1:17
Once-weekly semaglutide in people with HFpEF and obesity
1:31
Should ABPM parameters have a role in clinical practice?
1:09
On the most important key points on the diagnosis of Hypertension in the new ESH2023 guidelines
1:13
2023 ESC Guidelines for the Management of Endocarditis
1:37
How to measure blood pressure in the very obese patients?
1:14
The keypoints of 2023 ESC Guidelines for the Management of Cardiomyopathies
1:20
How to best perform office blood pressure management?
1:09
Key points from the newly updated ESC Heart Failure guidelines
0:54
Do overweight and obesity confer an additional risk of CAD in patients with FH?
1:17
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
1:17
The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA
1:15
The issue of adjuvant vs neoadjuvant treatment
1:19
The treatment sequence in metastatic melanoma
1:12
LMWH use in pregnancy: The ALPINE trial
1:19
Functional Precision Medicine in Oncology
1:10
The first mRNA cancer vaccine with pembrolizumab minimizes recurrence rate in melanoma tells Jeffrey Weber clinical investigator
1:18
Elevated Lipoprotein(a) as a Risk Enhancing Factor for Atherosclerotic Cardiovascular Disease

Spotify episodes

Apple podcasts

Google podcasts

Partner

Search by Scientific Content
Search by Congress
Search:
Date
Filters:
Lung Cance
13:28
Title Description

Lung Cancer highlights of ESMO 2023 Congress

Presenter: Luis Paz-Ares
Oncology
ESMO 2023
The import
14:17
Title Description

The importance of intensive lipid lowering in CV risk reduction: the role of early combination treatment

Presenter: Alberto Zambon
Cardiology
ESC 2023
State of a
10:39
Title Description

State of art lipid-lowering treatment in 2023

Presenter: Stephen J. Nicholls
Cardiology
ESC 2023
Lung cance
10:26
Title Description

Lung cancer highlights of the ESMO 2023 Congress

Presenter: Benjamin Besse
Oncology
ESMO 2023
Genitourin
11:41
Title Description

Genitourinary cancer highlights of ESMO 2023 Congress

Presenter: Silke Gillessen
Oncology
ESMO 2023
RCC highli
6:30
Title Description

RCC highlights of ESMO 2023 Congress

Presenter: Camillo Porta
Oncology
ESMO 2023
Melanoma h
8:15
Title Description

Melanoma highlights of ESMO 2023 Congress

Presenter: Karijn Suijkerbuijk
Oncology
ESMO 2023
Breast Can
12:18
Title Description

Breast Cancer highlights of the ESMO 2023 Congress

Presenter: Hope Rugo
Oncology
ESMO 2023
Antibody-D
3:04
Title Description

Antibody-Drug Conjugate Boosts Survival in Recurrent/Metastatic Cervical Cancer

Presenter: Krishnansu Sujata Tewari
Oncology
ESMO 2023
Treatment
7:53
Title Description

Treatment of mRCC in real world settings

Presenter: Daniel Heng
Oncology
ESMO 2023
KEYNOTE-94
7:47
Title Description

KEYNOTE-942 mRNA-Based vaccine and novel techniques in the field of melanoma

Presenter: Jeffrey Weber
Oncology
ESMO 2023
Late-break
4:43
Title Description

Late-breaking studies from ESMO 2023

Presenter: Pawel Sobczuk
Oncology
ESMO 2023
Data Shows
5:14
Title Description

Data Shows Survival Benefits with Tisotumab Vedotin in Cervical Cancer

Presenter: Ignace B. Vergote
Oncology
ESMO 2023
Induction
3:22
Title Description

Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer

Presenter: Mary McCormack
Oncology
ESMO 2023
Better use
2:47
Title Description

Better use of existing drugs increases cervical cancer survival and reduces recurrence

Presenter: Krishnansu Sujata Tewari
Oncology
ESMO 2023
Targeted C
5:56
Title Description

Targeted Combination Wins in KRAS-Positive Metastatic Colorectal Cancer

Presenter: Filippo Pietrantonio
Oncology
ESMO 2023

Lectures

Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease: Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology
How to man
1:00
Title Description

How to manage isolated systolic hypertension in the young?

Presenter: Paolo Palatini
Cardiology
Blood pres
1:34
Title Description

Blood pressure monitoring in general and what we can do to encourage people.

Presenter: Neil Poulter
Cardiology
How to man
1:08
Title Description

How to manage masked and masked uncontrolled hypertension?

Presenter: Paolo Palatini
Cardiology
ESMO 2023
1:13
Title Description

ESMO 2023 Scientific Chair's welcome and invitation to next year's ESMO Congress

Presenter: Silke Gillessen
Oncology
Once-weekl
1:17
Title Description

Once-weekly semaglutide in people with HFpEF and obesity

Presenter: Mikhail Kosiborod
Cardiology
Should ABP
1:31
Title Description

Should ABPM parameters have a role in clinical practice?

Presenter: Paolo Palatini
Cardiology
On the mos
1:09
Title Description

On the most important key points on the diagnosis of Hypertension in the new ESH2023 guidelines

Presenter: Bryan Williams
Cardiology
2023 ESC G
1:13
Title Description

2023 ESC Guidelines for the Management of Endocarditis

Presenter: Michael A. Borger
Cardiology
How to mea
1:37
Title Description

How to measure blood pressure in the very obese patients?

Presenter: Paolo Palatini
Cardiology
The keypoi
1:14
Title Description

The keypoints of 2023 ESC Guidelines for the Management of Cardiomyopathies

Presenter: Juan Pablo Kaski
Cardiology
How to bes
1:20
Title Description

How to best perform office blood pressure management?

Presenter: Paolo Palatini
Cardiology
Key points
1:09
Title Description

Key points from the newly updated ESC Heart Failure guidelines

Presenter: Marco Metra
Cardiology
Do overwei
0:54
Title Description

Do overweight and obesity confer an additional risk of CAD in patients with FH?

Presenter: Amany Elshorbagy
Cardiology
Interrupti
1:17
Title Description

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Presenter: Matteo Lambertini
Oncology
The Omega-
1:17
Title Description

The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA

Presenter: Eliot A. Brinton
Cardiology
The issue
1:15
Title Description

The issue of adjuvant vs neoadjuvant treatment

Presenter: Paolo A. Ascierto
Oncology